APA (7th ed.) Citation

Zhen Gao, Shujie Huang, Sichao Wang, Dezhao Tang, Wei Xu, Ruijie Zeng, & Guibin Qiao. (2023). Does nivolumab combined with fluorouracil-based chemotherapy produce higher objective response rate than other immunochemotherapy regimes in metastatic esophageal cancer?: Authors reply. Elsevier.

Chicago Style (17th ed.) Citation

Zhen Gao, Shujie Huang, Sichao Wang, Dezhao Tang, Wei Xu, Ruijie Zeng, and Guibin Qiao. Does Nivolumab Combined with Fluorouracil-based Chemotherapy Produce Higher Objective Response Rate than Other Immunochemotherapy Regimes in Metastatic Esophageal Cancer?: Authors Reply. Elsevier, 2023.

MLA (9th ed.) Citation

Zhen Gao, et al. Does Nivolumab Combined with Fluorouracil-based Chemotherapy Produce Higher Objective Response Rate than Other Immunochemotherapy Regimes in Metastatic Esophageal Cancer?: Authors Reply. Elsevier, 2023.